Returns | 1W : 6.4% , 1M : 4.4%,1Y : 79.4% |
LT :   |
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive] Debt : High |
ST :   |
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward Pledged Shares : None or < 25% |
Peers & Returns | 1W | 1M | 1Y |
GUFIC BIOSCIENCES | 6.4% | 4.4% | 79.4% |
SUN PHARMACEUTICAL INDUSTRIES | 3.4% | 6.4% | 39.2% |
DR REDDYS LABORATORIES | -0.4% | 11.7% | 26.7% |
DIVIS LABORATORIES | 0.6% | 12.6% | 59.7% |
CIPLA | 4.8% | 19.4% | 56.3% |
BIOCON | 0.6% | 3.5% | 18% |
AUROBINDO PHARMA | 5.4% | 14.8% | 74.8% |
LUPIN | 1.5% | 0.6% | 27.8% |
TORRENT PHARMACEUTICALS | 1.6% | 5% | 12.5% |
Ratio | Value |
---|---|
P/E P/B P/S |
39.27
P/E Calculated based on EPS of 2.94
[ Mar2020 - Standalone Results ] 9.37
P/B Calculated based on Book Value of 12.32
[ Mar2020 - Standalone Results ] 2.81
P/S Calculated based on Revenues of 319.504 Cr
[ TTM - Standalone Results ] |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
51% 76% 86% |
Pledged Shares |
0 % |
---|---|
As on : Sep2020 | |
If less than 25% | Good |
If between 25% and 50% | Neutral |
If greater than 50% | Bad |
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE HEALTHCARE | 2.5% | 9.5% | 53.4% |
S&P BSE MIDSMALLCAP | 0.6% | -2.9% | 87.1% |
S&P BSE SMALL CAP | 0.6% | -2.3% | 99.4% |
S&P BSE ALLCAP | 0.5% | -3.5% | 67.3% |